JATT II Acquisition Corp

JATT II Acquisition Corp(JATT)の株式分析

$10.340

+0.091 (+0.88%)終値時点

Loading chart…
高値
10.340
始値
10.275
出来高加重平均価格
10.32
出来高
658.00
時価総額
—
安値
10.275
売買代金
6.79K
EV/EBITDA(TTM)
0.00

JATT II Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. The Company is not engaged in any business operations and has not generated any revenue.

AI分析 of JATT II Acquisition Corp (JATT)

中立

Currently, Zura Bio Ltd (JATT) is not a strong buy due to its low price performance and negative earnings. The stock is trading at $10.25, which is only 1.9% above its 52-week low of $9.99. Additionally, the RSI is at 35.681, indicating that the stock is approaching oversold territory but is not yet a clear buy signal. The forward P/E ratio is 0, showing no expected earnings growth, which raises concerns about its profitability.

バリュエーション指標

JATT II Acquisition Corp(JATT)の現在の予想PERは0.00で、5年平均はです。

予想PER

5年平均 P/E
現在のP/E
0.00

予想EV/EBITDA

5年平均 EV/EBITDA
現在のEV/EBITDA
0.00

予想PSR

5年平均 P/S
現在のP/S
0.00

JATT を保有するクジラ

C

Commodore Capital LP

+ を保有JATT

+40.77%

3か月リターン

イベントタイムライン

2026-08-21 (ET)

10:00:00

Jatt II Acquisition Corp Trading Halted Due to Volatility

2026-06-29 (ET)

10:00:00

JATT II Acquisition Corp Ordinary Shares Trading Halted

07:30:00

Talawar Tx and JATT II to Merge, Expected to Raise $285 Million

2026-04-20 (ET)

11:30:00

AEVEX Opens Above $20 in IPO Debut

ニュース

JATT のよくある質問 — Alphio AI が回答

JATT II Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. The Company is not engaged in any business operations and has not generated any revenue. It operates in the Financials sector.

Currently, Zura Bio Ltd (JATT) is not a strong buy due to its low price performance and negative earnings. The stock is trading at $10.25, which is only 1.9% above its 52-week low of $9.99. Additionally, the RSI is at 35.681, indicating that the stock is approaching oversold territory but is not yet a clear buy signal. The forward P/E ratio is 0, showing no expected earnings growth, which raises concerns about its profitability.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める